Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies

Ahn, S; Lee, Y; Kim, JW; Lee, JC; Hwang, JH; Yoon, YS; Cho, JY; Han, HS; Choi, Y; Kim, H

Kim, H (reprint author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, 103 Daehak Ro, Seoul 03080, South Korea.

HISTOPATHOLOGY, 2019; 75 (4): 526

Abstract

Aims Pembrolizumab has shown promising results for patients with programmed cell death ligand-1 (PD-L1)-positive advanced biliary tract cancer in an o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索